Accelerate to discover

Back to filter

Related topics

Low-dose imaging in a new preclinical total-body PET/CT scanner

Bruker Biospin

Jun 12, 2019

Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...

Fluxion Biosciences and National Cancer Institute cooperate to validate IsoFlux for sequencing

Fluxion Biosciences

Jun 12, 2019

Fluxion with IsoFlux has partnered with the Cleveland Clinic. They are aiming to improve sensitivity by timing the...

New insight into Cas9 off-target activity

LUMICKS

Jun 7, 2019

Scientists at the MRC London Institute of Medical Sciences and AstraZeneca studied how CRISPR-Cas9 differentiates...

IncuCyte virtual event: Dimension of time - from culture to assay

Sartorius

Jun 5, 2019

This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....

Jun 17, 2019

Join the AVANCE Track & Keep your MRI on Track

Bruker Biospin

Jun 4, 2019

Your research depends on the scientific advances that you make with your MRI instrument. Take your instrument and your...

A novel method for isolating high-quality UHMW DNA from animal and human tissues

BioNano Genomics

May 31, 2019

New isolation protocol for isolating high-quality UHMW DNA from 10 mg of freshly frozen or liquid-preserved animal and...

From incubation to publication with IncuCyte S3 live-cell imaging system

Sartorius

May 29, 2019

Over 2000 peer-reviewed publications worldwide and growing. Explore the IncuCyte publications library, an up-to-date...

Jun 17, 2019

ParaVision 7 software

Bruker Biospin

May 27, 2019

The preclinical MRI software ParaVision 7 delivers unsurpassed image quality and enhanced productivity for both routine...

Show all topics (10)

ERASE-Seq: A Novel NGS statistical approach

Nov 21, 2017

Liquid biopsy assays have shown great promise as a precision medicine approach to therapy selection and patient monitoring, but significant sensitivity and specificity improvements are still needed. To address this we introduce ERASE-Seq (Elimination of recurrent artifacts and stochastic errors), a method for accurate and sensitive detection of ultra-low frequency DNA variants.
ERASE-Seq differs from previous methods by creating a variant event matrix that includes multiple sample runs and control data. A robust statistical framework is applied at each position in the sequence, providing a 10 to 100-fold reduction in false positive rates compared to published molecular barcoding methods.

Read more

Scientific paper
Technical breakthrough
Product news

Related technologies: CTC´s and rare cells analysis

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

Fluxion Biosciences

With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.

Related products

The Spotlight 59 Oncology Panel is a turnkey solution for Illumina sequencers, offering ultra-sensitive variant detection from low input quantities of DNA.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey